| Product Code: ETC9516738 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname saw a shift in its import sources for multiplex biomarker imaging shipments in 2024, with top exporters being the United States, Netherlands, China, Trinidad and Tobago, and Taiwan. The Herfindahl-Hirschman Index (HHI) indicated a very high concentration in 2023, which remained high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was -16.8%, with a significant decline in the growth rate from 2023 to 2024 at -43.05%. This data suggests a challenging market environment for multiplex biomarker imaging imports in Suriname.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Multiplex Biomarker Imaging Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Multiplex Biomarker Imaging Market - Industry Life Cycle |
3.4 Suriname Multiplex Biomarker Imaging Market - Porter's Five Forces |
3.5 Suriname Multiplex Biomarker Imaging Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 Suriname Multiplex Biomarker Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Suriname Multiplex Biomarker Imaging Market Revenues & Volume Share, By Imaging Techniques, 2021 & 2031F |
3.8 Suriname Multiplex Biomarker Imaging Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Suriname Multiplex Biomarker Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies in Suriname |
4.2.2 Technological advancements in multiplex biomarker imaging technologies |
4.2.3 Growing prevalence of chronic diseases requiring advanced diagnostic techniques |
4.3 Market Restraints |
4.3.1 High cost associated with multiplex biomarker imaging equipment and services |
4.3.2 Limited awareness and adoption of advanced diagnostic technologies in Suriname |
4.3.3 Regulatory challenges and lack of standardized guidelines for biomarker imaging procedures |
5 Suriname Multiplex Biomarker Imaging Market Trends |
6 Suriname Multiplex Biomarker Imaging Market, By Types |
6.1 Suriname Multiplex Biomarker Imaging Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Software, 2021- 2031F |
6.1.5 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Suriname Multiplex Biomarker Imaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Drug Safety, 2021- 2031F |
6.2.3 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Oncology Studies, 2021- 2031F |
6.2.4 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Genetic Characterization Studies, 2021- 2031F |
6.3 Suriname Multiplex Biomarker Imaging Market, By Imaging Techniques |
6.3.1 Overview and Analysis |
6.3.2 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Immuno Fluorescence Assay, 2021- 2031F |
6.3.3 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Tissue Microarray Assay, 2021- 2031F |
6.3.4 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Immunohistochemistry Assay, 2021- 2031F |
6.3.5 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Fluorescent in the Situ Hybridization Assay, 2021- 2031F |
6.3.6 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Toponome Imaging System, 2021- 2031F |
6.4 Suriname Multiplex Biomarker Imaging Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Research Institutes Government & Private, 2021- 2031F |
6.4.3 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Pharmaceutical & Biotechnology, 2021- 2031F |
6.4.4 Suriname Multiplex Biomarker Imaging Market Revenues & Volume, By Clinical Labs, 2021- 2031F |
7 Suriname Multiplex Biomarker Imaging Market Import-Export Trade Statistics |
7.1 Suriname Multiplex Biomarker Imaging Market Export to Major Countries |
7.2 Suriname Multiplex Biomarker Imaging Market Imports from Major Countries |
8 Suriname Multiplex Biomarker Imaging Market Key Performance Indicators |
8.1 Adoption rate of multiplex biomarker imaging technologies in healthcare facilities in Suriname |
8.2 Number of research and development collaborations focused on biomarker imaging in Suriname |
8.3 Rate of incorporation of multiplex biomarker imaging in clinical trials for drug development in Suriname |
9 Suriname Multiplex Biomarker Imaging Market - Opportunity Assessment |
9.1 Suriname Multiplex Biomarker Imaging Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 Suriname Multiplex Biomarker Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Suriname Multiplex Biomarker Imaging Market Opportunity Assessment, By Imaging Techniques, 2021 & 2031F |
9.4 Suriname Multiplex Biomarker Imaging Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Suriname Multiplex Biomarker Imaging Market - Competitive Landscape |
10.1 Suriname Multiplex Biomarker Imaging Market Revenue Share, By Companies, 2024 |
10.2 Suriname Multiplex Biomarker Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here